Trial intelligence / Profile preview

Electroacupuncture Intervention on Immune Cells in Herpes Zoster

NCT06643247Recruiting

Sponsor
Hangzhou First People's Hospital
Start
Nov 2024
Primary completion
Dec 2027
Countries
1
01

Overview

Randomised, open-label trial in herpes zoster (HZ) (3 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Peripheral blood immune cell levels at Day 7. Started Nov 2024; status: recruiting.

02

Conditions

herpes zoster (HZ)

Beyond the preview

Go deeper on NCT06643247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06643247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call